Could a stronger antibiotic dose keep cellulitis patients out of hospital?

NCT ID NCT05852262

Completed Disease control Sponsor: Ottawa Hospital Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This study tests whether a higher dose of the oral antibiotic cephalexin can better treat cellulitis, a common skin infection, in adults visiting the emergency room. About 446 participants will receive either a high or standard dose to see if it reduces the need for changing antibiotics or hospitalization. The goal is to improve treatment success and lower healthcare costs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELLULITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cellulitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CELLULITIS

Contacts and locations

Locations

Enfant-Jésus Hospital

Québec, Quebec, Canada
Health Sciences North

Greater Sudbury, Ontario, P3E 2H2, Canada
Hôpital du Sacré-Cœur de Montréal

Montreal, Quebec, Canada
Kingston Health Sciences Centre

Kingston, Ontario, Canada
London Health Sciences Centre

London, Ontario, Canada
Queen Elisabeth II Health Sciences Centre

Halifax, Nova Scotia, Canada
Sinai Health System

Toronto, Ontario, Canada
South Health Campus

Calgary, Alberta, Canada
The Ottawa Hospital

Ottawa, Ontario, K1Y 4E9, Canada
Thunder Bay Health Sciences Centre

Thunder Bay, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.